statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire BEDFORD...

Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update

StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM - Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the biotechnology...

Pulmatrix (NASDAQ:PULM) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM - Free Report) in a report released on Sunday. The firm issued a hold rating on the biotechnology company's stock.
Pulmatrix Stock Up...

Pulmatrix (NASDAQ:PULM) Now Covered by Analysts at StockNews.com

Pulmatrix ( NASDAQ:PULM ) Full Year 2023 Results Key Financial Results Revenue: US$7.30m (up 20% from FY 2022). Net...

Pulmatrix Full Year 2023 Earnings: US$3.87 loss per share (vs US$5.46 loss in FY 2022)

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
PULM stock results show that Pulmatrix beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of...

PULM Stock Earnings: Pulmatrix Beats EPS, Beats Revenue for Q4 2023

Pulmatrix GAAP EPS of -$3.87, revenue of $7.3M...

Pulmatrix GAAP EPS of -$3.87, revenue of $7.3M

Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update PR Newswire BEDFORD...

Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update

Equities research analysts at StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM  Get Free Report) in a research report issued to clients and investors on Saturday. The firm set...

Pulmatrix (NASDAQ:PULM) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM  Free Report) in a research note released on Thursday morning. The firm issued a hold rating on the biotechnology...

StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM  Free Report) in a research report report published on Wednesday morning. The firm issued a hold rating on the biotechnology...

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Bedford, MA.

Watchers	20,623
52-Wk Low	$1.55
52-Wk High	$2.91

Volume	44,325.00
52-Wk High	$2.91
52-Wk Low	$1.55

PULM Pulmatrix Inc

About

Feed

News

Fundamentals